Evidence map›Paper›PMID 29328377›Full record

ArticleMolecular medicine reports2018

Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.

Youlin Tuo, Ning An, Ming Zhang

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Computational and structural biotechnology journal · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Youlin TuoDepartment of Breast Surgery, Sichuan Provincial People's Hospital, Sichuan Academy of Medical Sciences, School of Clinical Medicine of University of Electronic Science and Technology of China, Chengdu, Sichuan 610000, P.R. China.
Ning AnDepartment of Oncology, Sichuan Provincial People's Hospital, Sichuan Academy of Medical Sciences, School of Clinical Medicine of University of Electronic Science and Technology of China, Chengdu, Sichuan 610000, P.R. China.
Ming ZhangDepartment of Oncology, Sichuan Provincial People's Hospital, Sichuan Academy of Medical Sciences, School of Clinical Medicine of University of Electronic Science and Technology of China, Chengdu, Sichuan 610000, P.R. China.
University of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the feature genes in metastatic breast cancer samples. A total of 5 expression profiles of metastatic breast cancer samples were downloaded from the Gene Expression Omnibus database, which were then analyzed using the MetaQC and MetaDE packages in R language. The feature genes between metastasis and non‑metastasis samples were screened under the threshold of P<0.05. Based on the protein‑protein interactions (PPIs) in the Biological General Repository for Interaction Datasets, Human Protein Reference Database and Biomolecular Interaction Network Database, the PPI network of the feature genes was constructed. The feature genes identified by topological characteristics were then used for support vector machine (SVM) classifier training and verification. The accuracy of the SVM classifier was then evaluated using another independent dataset from The Cancer Genome Atlas database. Finally, function and pathway enrichment analyses for genes in the SVM classifier were performed. A total of 541 feature genes were identified between metastatic and non‑metastatic samples. The top 10 genes with the highest betweenness centrality values in the PPI network of feature genes were Nuclear RNA Export Factor 1, cyclin‑dependent kinase 2 (CDK2), myelocytomatosis proto‑oncogene protein (MYC), Cullin 5, SHC Adaptor Protein 1, Clathrin heavy chain, Nucleolin, WD repeat domain 1, proteasome 26S subunit non‑ATPase 2 and telomeric repeat binding factor 2. The cyclin‑dependent kinase inhibitor 1A (CDKN1A), E2F transcription factor 1 (E2F1), and MYC interacted with CDK2. The SVM classifier constructed by the top 30 feature genes was able to distinguish metastatic samples from non‑metastatic samples [correct rate, specificity, positive predictive value and negative predictive value >0.89; sensitivity >0.84; area under the receiver operating characteristic curve (AUROC) >0.96]. The verification of the SVM classifier in an independent dataset (35 metastatic samples and 143 non‑metastatic samples) revealed an accuracy of 94.38% and AUROC of 0.958. Cell cycle associated functions and pathways were the most significant terms of the 30 feature genes. A SVM classifier was constructed to assess the possibility of breast cancer metastasis, which presented high accuracy in several independent datasets. CDK2, CDKN1A, E2F1 and MYC were indicated as the potential feature genes in metastatic breast cancer.

Indexed as

Gene Expression Regulation, NeoplasticGene Regulatory NetworksBiomarkers, TumorBreast NeoplasmsCyclin-Dependent Kinase 2Cyclin-Dependent Kinase Inhibitor p21Databases, GeneticE2F1 Transcription FactorFemaleGene Expression ProfilingGene OntologyHumansMolecular Sequence AnnotationNeoplasm MetastasisOligonucleotide Array Sequence AnalysisProtein Interaction MappingBiomarkers, TumorCDK2 protein, humanCDKN1A protein, humanCyclin-Dependent Kinase 2Cyclin-Dependent Kinase Inhibitor p21E2F1 protein, humanE2F1 Transcription FactorMYC protein, humanProto-Oncogene Proteins c-mycbreast cancerfeature genemetastasisprotein-protein interactionssupport vector machine classifier

Identifiers

PMID29328377
PMCPMC5802200
OpenAlexW2783334502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.